Simon Tazzyman

3.5k total citations · 2 hit papers
25 papers, 2.2k citations indexed

About

Simon Tazzyman is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Simon Tazzyman has authored 25 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cell Biology and 7 papers in Immunology. Recurrent topics in Simon Tazzyman's work include Virus-based gene therapy research (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and Immune cells in cancer (4 papers). Simon Tazzyman is often cited by papers focused on Virus-based gene therapy research (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and Immune cells in cancer (4 papers). Simon Tazzyman collaborates with scholars based in United Kingdom, United States and Switzerland. Simon Tazzyman's co-authors include Claire E. Lewis, Craig Murdoch, Russell Hughes, Steve J. Webster, Nicola J. Brown, Carolyn A. Staton, Michele De Palma, Ioanna Keklikoglou, Jeffrey W. Pollard and Stephen M. Stribbling and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Simon Tazzyman

25 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models

2018 414 citations Ioanna Keklikoglou, Chiara Cianciaruso et al. Nature Cell Biology profile →
Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy

2015 399 citations Russell Hughes, Bin‐Zhi Qian et al. Cancer Research profile →

Peers

Countries citing papers authored by Simon Tazzyman

Since Specialization

Citations

This map shows the geographic impact of Simon Tazzyman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Tazzyman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Tazzyman more than expected).

Fields of papers citing papers by Simon Tazzyman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Tazzyman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Tazzyman. The network helps show where Simon Tazzyman may publish in the future.

Co-authorship network of co-authors of Simon Tazzyman

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Tazzyman. A scholar is included among the top collaborators of Simon Tazzyman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Tazzyman. Simon Tazzyman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HSV1716 Prevents Myeloma Cell Regrowth When Combined with Bortezomib In Vitro and Significantly Reduces Systemic Tumor Growth in Mouse Models 2023 ·Viruses ·Simon Tazzyman, (unknown), (unknown), (unknown), Darren Lath, Joe Conner, Munitta Muthana, Andrew Chantry, Michelle A. Lawson	4
2	The Autoimmune Susceptibility Gene C5orf30 Regulates Macrophage-Mediated Resolution of Inflammation 2019 ·The Journal of Immunology ·Emma Dorris, Simon Tazzyman, (unknown), Nandhini Ramamoorthi, Jason A. Hackney, Michael J. Townsend, Munitta Muthana, Myles Lewis, Costantino Pitzalis, Anthony G. Wilson	11
3	Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models breakdown → 2018 ·Nature Cell Biology ·Ioanna Keklikoglou, Chiara Cianciaruso, Esra Güç, Mario Leonardo Squadrito, Laura M. Spring, Simon Tazzyman, (unknown), Amanda Poissonnier, Gino B. Ferraro, Caroline Baer, (unknown), Alan Guichard, M. Luisa Iruela‐Arispe, Claire E. Lewis, Lisa M. Coussens, Aditya Bardia, Rakesh K. Jain, Jeffrey W. Pollard, Michele De Palma	414
4	Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models 2018 ·Journal of Bone and Mineral Research ·Julia Paton‐Hough, Simon Tazzyman, Holly Evans, Darren Lath, Jenny Down, Alanna C. Green, John A. Snowden, Andrew Chantry, Michelle A. Lawson	16
5	Zebrafish xenograft models of cancer and metastasis for drug discovery 2017 ·Expert Opinion on Drug Discovery ·Hannah K. Brown, (unknown), Simon Tazzyman, Dominique Heymann, Tim Chico	90
6	Zebrafish as a new model to study effects of periodontal pathogens on cardiovascular diseases 2016 ·Scientific Reports ·Magdalena Widziołek, Tomasz K. Prajsnar, Simon Tazzyman, Graham P. Stafford, Jan Potempa, Craig Murdoch	27
7	Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy breakdown → 2015 ·Cancer Research ·Russell Hughes, Bin‐Zhi Qian, Charlotte Rowan, Munitta Muthana, Ioanna Keklikoglou, Oakley C. Olson, Simon Tazzyman, Sarah Danson, Christina Addison, Mark Clemons, Ana M. González-Angulo, Johanna A. Joyce, Michele De Palma, Jeffrey W. Pollard, Claire E. Lewis	399
8	Vitamin D associates with improved quality of life in participants with irritable bowel syndrome: outcomes from a pilot trial 2015 ·BMJ Open Gastroenterology ·Simon Tazzyman, (unknown), (unknown), Amy Evans, (unknown), Iveta Garaiová, Sue Plummer, Elizabeth A. Williams, Bernard M. Corfe	39
9	Development of a Trojan horse oncolytic virus for treatment of myeloma. 2015 ·Journal of Clinical Oncology ·Simon Tazzyman, Munitta Muthana, (unknown), Claire E. Lewis, Joe Conner, Andrew Chantry	3
10	Loss of Function of Parathyroid Hormone Receptor 1 Induces Notch-Dependent Aortic Defects During Zebrafish Vascular Development 2013 ·Arteriosclerosis Thrombosis and Vascular Biology ·Caroline Gray, D Bratt, (unknown), Marc Da Costa, Karen Plant, Oliver J. Watson, (unknown), Simon Tazzyman, Jovana Serbanovic‐Canic, David C. Crossman, Bernard Keavney, Andrea Haase, Kathryn McMahon, Martin Gering, Henry Roehl, Paul C. Evans, Tim Chico	11
11	Macrophage Delivery of an Oncolytic Virus Abolishes Tumor Regrowth and Metastasis after Chemotherapy or Irradiation 2012 ·Cancer Research ·Munitta Muthana, (unknown), Yung‐Yi Chen, Abigail Welford, Russell Hughes, Simon Tazzyman, Magnus Essand, (unknown), Claire E. Lewis	86
12	Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2‐specific antagonist is associated with reduced tumor growth 2011 ·International Journal of Cancer ·Simon Tazzyman, Simon T. Barry, Susan Ashton, Pauline J. Wood, David C. Blakey, Claire E. Lewis, Craig Murdoch	89
13	A novel fragment derived from the β chain of human fibrinogen, β43–63, is a potent inhibitor of activated endothelial cells in vitro and in vivo 2010 ·British Journal of Cancer ·(unknown), Claire E. Lewis, Yung‐Yi Chen, Abigail Welford, Simon Tazzyman, C A Staton	13
14	Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors 2009 ·Gene Therapy ·Rachel Ryan, (unknown), Patrick J. Williams, Simon Tazzyman, Stuart Hunt, Judith H. Harmey, S.C. Kehoe, Claire E. Lewis	143
15	Hypoxia-induced secretion of macrophage migration-inhibitory factor from MCF-7 breast cancer cells is regulated in a hypoxia-inducible factor-independent manner 2008 ·Cancer Letters ·(unknown), Simon Tazzyman, Eva Løbner Lund, Nanna Junker, Claire E. Lewis, Paul E.G. Kristjansen, Craig Murdoch	32
16	Identification of key residues involved in mediating the in vivo anti‐tumor/anti‐endothelial activity of Alphastatin 2007 ·Journal of Thrombosis and Haemostasis ·C A Staton, Stephen M. Stribbling, Carlos Garcı́a-Echeverrı́a, Jonathan Bury, Simon Tazzyman, Claire E. Lewis, Nicola J. Brown	12
17	Expression of Tie-2 by Human Monocytes and Their Responses to Angiopoietin-2 2007 ·The Journal of Immunology ·Craig Murdoch, Simon Tazzyman, Steve J. Webster, Claire E. Lewis	250
18	Current methods for assaying angiogenesisin vitroandin vivo 2004 ·International Journal of Experimental Pathology ·Carolyn A. Staton, Stephen M. Stribbling, Simon Tazzyman, Russell Hughes, Nicola J. Brown, Claire E. Lewis	266
19	Alphastatin, a 24–amino acid fragment of human fibrinogen, is a potent new inhibitor of activated endothelial cells in vitro and in vivo 2003 ·Blood ·Carolyn A. Staton, Nicola J. Brown, (unknown), Kevin P. Corke, Simon Tazzyman, James Underwood, Claire E. Lewis	49
20	Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro 2001 ·Angiogenesis ·(unknown), Simon Tazzyman, W. D. Thompson, C.M. Stirk, Claire E. Lewis	95

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact